SCHEMBL7067474

SCHEMBL7067474

N#CC(=Cc1cccs1)c1n[nH]c(N)c1C#N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.48
▸ RAB9A P51151 5/20 0.48
▸ MAPT P10636 6/20 0.46
▸ KMT2A Q03164 6/20 0.46
▸ LMNA P02545 4/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ POLB P06746 2/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.38
▸ HPGD P15428 2/20 0.38
▸ NR1I2 O75469 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ KDR P35968 1/20 0.36
▸ MAPK1 P28482 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067471 1.00 NPC1 (0.48) NPC1RAB9AMAPTKMT2ALMNA
SCHEMBL7073978 0.75 MAPT (0.44) RAB9AMAPTKMT2ALMNASMN1; SMN2
SCHEMBL7073980 0.75 MAPT (0.44) RAB9AMAPTKMT2ALMNASMN1; SMN2
SCHEMBL7074094 0.73 PIP4K2A (0.43) MAPTKMT2ALMNAMEN1ALDH1A1
SCHEMBL7066943 0.72 MAPT (0.39) MAPTKMT2ALMNAMEN1POLB
SCHEMBL7066942 0.72 MAPT (0.39) MAPTKMT2ALMNAMEN1POLB
SCHEMBL1889486 0.72 NPC1 (0.59) NPC1RAB9AMAPTKMT2ALMNA
SCHEMBL7071008 0.71 CYP2A6 (0.40) NPC1RAB9AMAPTKMT2ALMNA
SCHEMBL7071012 0.71 CYP2A6 (0.40) NPC1RAB9AMAPTKMT2ALMNA
SCHEMBL4909719 0.68 KMT2A (0.63) NPC1RAB9AMAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134862-A1 Compounds BIOVITRUM AB (SE) 2003-07-17 — — US disclosed
WO-2003053976-A1 PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR BIOVITRUM AB (SE) 2003-07-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134862-A1 Compounds PPARG, PPARA, PPARD NPC1 2837/4885RAB9A 3199/4885MAPT 4576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback